Clovis Oncology, Inc. (NASDAQ:CLVS) is gaining traction with investors, as evidenced by its 1 million shares volume. The daily trading volume average remained 1.64 million shares over the course of 3 months. The stock had opened the regular trading at $82.79 and managed a 1.73% price change to reach $84.21 through the close.Clovis Oncology, Inc. (CLVS) Analyst Opinion
Clovis Oncology, Inc. has a consensus outperform rating from 13 Wall Street analysts, and the number of shares currently sold short amount to at least 16.76% of shares outstanding. The stock spiked 18.97% last month and is up 89.58 this year. Wall Street is only getting more bullish on the stock, with 9 of analysts who cover CLVS having a buy-equivalent rating. Analysts have placed a $93.73 price target on Clovis Oncology, Inc., suggesting a 11.31% gain from recent close. It’s currently trading about -15.32% below its 52-week high.Clovis Oncology, Inc. Earnings Surprise
Clovis Oncology, Inc. (CLVS) surprised the stock market in its last reported earnings when it earned -$1.29 a piece versus the consensus-estimated -$2.13. Its revenue totaled $13.31 million up 88.79% from the previous quarter.Clovis Oncology, Inc. (NASDAQ:CLVS) Intraday View
This stock (CLVS) is ahead of its 52-week low with 226.27%. Its last month’s stock price volatility remained 3.47% which for the week stands at 4.86%. The share price has moved forward from its 20 days moving average, trading at a distance of 7.12% and stays 11.82% away from its 50 days moving average. Over the last five days, shares have managed 1.18% gains and now is up 25.15% since hitting its 200-day moving average of $70.87. Clovis Oncology, Inc. (CLVS) has made its way to a 12-month gain of 157.68%.
Turning to Starbucks Corporation (NASDAQ:SBUX), its shares were trading at $55.97 a gain of $0.33, on the trading floor. The stock, after opening at $55.67, touched a high of $56.27 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. Starbucks Corporation has 12 buy ratings, 9 holds and 0 sells even after the stock tumbled -13.72% from its high of $64.87 to a $79.82 billion market value through last close.Starbucks Corporation (SBUX) Consensus Price Target
The company’s consensus rating on Reuter’s scale remained unchanged from 1.91 to 1.91 during a month. Analysts set a 12-month price target of $64.09 a share. The target implies a 14.51% spike from where the shares are currently trading. Also, the current price highlights a discount of 34% to analysts’ high consensus price target.Starbucks Corporation (NASDAQ:SBUX) Intraday Trading
The counter witnessed a trading volume of 7.21 million shares versus an average volume of 10.15 million shares during last trading session. Its last month’s stock price volatility remained 1.46% which for the week approaches 1.12%. The lowest price the stock reached in the last trading day was $55.31 and compares with the $50.84 52-week low. The stock recovered 10.09% since its low point and has performed 0.81% year-to-date.